Skerra A - Search Results

1

Anticalin^® Proteins as Therapeutic Agents in Human Diseases.

Rothe C, Skerra A. Rothe C, et al. Among authors: skerra a. BioDrugs. 2018 Jun;32(3):233-243. doi: 10.1007/s40259-018-0278-1. BioDrugs. 2018. PMID: 29748739 Free PMC article. Review.

2

Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant -- a so-called 'anticalin' -- using a molecular random approach.

Schlehuber S, Skerra A. Schlehuber S, et al. Among authors: skerra a. Biophys Chem. 2002 May 2;96(2-3):213-28. doi: 10.1016/s0301-4622(02)00026-1. Biophys Chem. 2002. PMID: 12034442

3

Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D.

Vogt M, Skerra A. Vogt M, et al. Among authors: skerra a. Chembiochem. 2004 Feb 6;5(2):191-9. doi: 10.1002/cbic.200300703. Chembiochem. 2004. PMID: 14760740

4

Anticalins in drug development.

Schlehuber S, Skerra A. Schlehuber S, et al. Among authors: skerra a. BioDrugs. 2005;19(5):279-88. doi: 10.2165/00063030-200519050-00001. BioDrugs. 2005. PMID: 16207069

5

Rational engineering of a fluorescein-binding anticalin for improved ligand affinity.

Vopel S, Mühlbach H, Skerra A. Vopel S, et al. Among authors: skerra a. Biol Chem. 2005 Nov;386(11):1097-104. doi: 10.1515/BC.2005.126. Biol Chem. 2005. PMID: 16307475

6

Anticalins as alternative binding proteins for therapeutic use.

Skerra A. Skerra A. Curr Opin Mol Ther. 2007 Aug;9(4):336-44. Curr Opin Mol Ther. 2007. PMID: 17694446 Review.

7

High-throughput sorting of an Anticalin library via EspP-mediated functional display on the Escherichia coli cell surface.

Binder U, Matschiner G, Theobald I, Skerra A. Binder U, et al. Among authors: skerra a. J Mol Biol. 2010 Jul 23;400(4):783-802. doi: 10.1016/j.jmb.2010.05.049. Epub 2010 May 26. J Mol Biol. 2010. PMID: 20630471

8

Anticalins small engineered binding proteins based on the lipocalin scaffold.

Gebauer M, Skerra A. Gebauer M, et al. Among authors: skerra a. Methods Enzymol. 2012;503:157-88. doi: 10.1016/B978-0-12-396962-0.00007-0. Methods Enzymol. 2012. PMID: 22230569 Review.

9

Combinatorial design of an Anticalin directed against the extra-domain b for the specific targeting of oncofetal fibronectin.

Gebauer M, Schiefner A, Matschiner G, Skerra A. Gebauer M, et al. Among authors: skerra a. J Mol Biol. 2013 Feb 22;425(4):780-802. doi: 10.1016/j.jmb.2012.12.004. Epub 2012 Dec 10. J Mol Biol. 2013. PMID: 23238252

10

Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins.

Richter A, Eggenstein E, Skerra A. Richter A, et al. Among authors: skerra a. FEBS Lett. 2014 Jan 21;588(2):213-8. doi: 10.1016/j.febslet.2013.11.006. Epub 2013 Nov 12. FEBS Lett. 2014. PMID: 24239535 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters